Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Patent watch

Nature Reviews Drug Discovery volume 12, pages 14–15 (2013)Cite this article

Subjects

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Worldwide sales at risk from patent expiration (2004–2018).

References

  1. EvaluatePharma. World Preview 2018 — Embracing the patent cliff. EvaluatePharma website [online], (2012).

  2. Palmer, E. Top 20 generic molecules worldwide. FiercePharma website [online], (2012).

  3. IMS Institute for Healthcare Informatics. The global use of medicines: outlook through 2016. IMS Health website [online], (2012).

  4. Medtrack. Medtrack Patent Report — 2013 expiring patents. (2011).

Download references

Authors
  1. Charlotte Harrison
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Harrison, C. Patent watch. Nat Rev Drug Discov 12, 14–15 (2013). https://doi.org/10.1038/nrd3924

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd3924

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing